MedTrace Logo

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

NCT00944853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 462

Last updated 2017-02-24

No results posted yet for this study

Summary

The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Conditions

  • Zinc Deficiency

Interventions

DIETARY_SUPPLEMENT

Liquid zinc syrup

Liquid zinc syrup containing 5 mg zinc as zinc sulfate

DIETARY_SUPPLEMENT

Zinc tablet

Dispersible zinc tablet containing 5 mg zinc

DIETARY_SUPPLEMENT

Liquid placebo supplement

Liquid placebo supplement containing 0 mg zinc

Sponsors & Collaborators

  • Université Polytechnique de Bobo-Dioulasso

    collaborator OTHER

  • Helen Keller International

    collaborator OTHER

  • Nutriset

    collaborator INDUSTRY

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Kenneth H Brown, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-12-31
Completion
2010-02-28

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00944853 on ClinicalTrials.gov